Companies /Healthcare
Ionis Pharmaceuticals Inc
NASDAQ: IONS Biotechnology
$42.70
▲ $0.32 (+0.76%) today
Markets closed · 9:25pm ET

Ionis Pharmaceuticals (IONS) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
83%
EPS beat rate
+65.52%
Avg. EPS surprise
Consecutive EPS beats
IONS vs Market · 30-day return after each reportIONSS&P 500
−7%0%+7%+14%+11.1%+6.9%Q1 25−1.7%+1.7%Q2 25+14.1%−1.0%Q3 25−10.9%−8.5%Q4 25+0.7%+6.6%Q1 26+13.0%+5.5%Q2 26
−7%0%+7%+14%Q1 25Q3 25Q1 26
IONS EPS Trend · estimate vs actualEstimateActual
$-1.20$-0.60$0.00$0.60$-1.03$-0.93Q1 25$0.16$0.70Q2 25$-1.05$-0.80Q3 25$-1.22$-1.41Q4 25$-0.78$-0.56Q1 26$-0.88$-0.69Q2 26
$-1.20$-0.60$0.00$0.60Q1 25Q3 25Q1 26
IONS Revenue Trend · estimate vs actualEstimateActual
$0$200.0M$400.0M$122.5M$132.0MQ1 25$299.0M$452.0MQ2 25$130.5M$157.0MQ3 25$156.1M$203.0MQ4 25$196.0M$246.0MQ1 26$190.1M$268.0MQ2 26
$0$200.0M$400.0MQ1 25Q3 25Q1 26

How Often Does Ionis Pharmaceuticals Beat Earnings Estimates?

Ionis Pharmaceuticals beat EPS estimates in 5 of its last 6 reported quarters, and has beaten 2 quarters in a row.

IONS quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $-0.69 est. $-0.88 +21.44% $268.0M est. $190.1M +40.99%
Q1 2026 $-0.56 est. $-0.78 +27.74% $246.0M est. $196.0M +25.50%
Q4 2025 $-1.41 est. $-1.22 −15.98% $203.0M est. $156.1M +30.02%
Q3 2025 $-0.80 est. $-1.05 +23.99% $157.0M est. $130.5M +20.30%
Q2 2025 $0.70 est. $0.16 +326.05% $452.0M est. $299.0M +51.18%
Q1 2025 $-0.93 est. $-1.03 +9.86% $132.0M est. $122.5M +7.75%

Figures from SEC filings and company reports. Not investment advice.